Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mobidiag Looks Inward To Solve COVID-19 Test Manufacturing Challenges

Executive Summary

With diagnostic companies facing supply chain issues and reagent shortages for COVID-19 tests, Finnish diagnostics company Mobidiag decided to take matters into its own hands. CEO Tuomas Tenkanen tells Medtech Insight how the company secured manufacturing capabilities in-house.

You may also be interested in...



Hologic Continues 2021 Spending Spree With $795M Acquisition Of Mobidiag

Mobidiag develops molecular diagnostic tests and instrumentation that will expand Hologic’s acute care testing capabilities.

Mobidiag Launches Automobi Joint Venture In China

Finnish diagnostics company Mobidiag has launched its new joint venture with partner Autobio Diagnostics called Automobi.

Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio

Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT142272

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel